CleanCore Solutions, Inc. (ZONE)

CleanCore Solutions manufactures and sells electrolyzed water — a liquid created by passing an electrical current through a saltwater solution to produce a disinfectant that the company markets as safer and less toxic than traditional chemical cleaners. The company targets healthcare facilities, food-service operations, and commercial cleaners who face pressure from regulators, insurers, and customers to reduce chemical exposure while maintaining effective infection control and sanitation. This positioning sits at the intersection of environmental and occupational-health trends: regulators tighten rules on chemical exposure, workers and patients demand less-toxic environments, and facility managers face rising costs for chemical-handling, waste disposal, and worker safety programs.

The core claim is simple: electrolyzed water disinfects as effectively as bleach and quaternary ammonia, but breaks down into salt and water afterward, leaving no toxic residue.

If that claim holds up in the field and in the market, CleanCore sits at the front of a substitution wave — replacing established chemical-cleaning protocols with a gentler, safer alternative. But the market for cleaning chemicals is vast, mature, and dominated by well-capitalized incumbents with established relationships, proven formulations, and pricing power. CleanCore must convince risk-averse facilities managers that the new approach is not just safer but cost-effective compared to products they know, which have years of proven field performance and regulatory approval history.

The electrolyzed water premise

Electrolyzed water is not new — the chemistry dates back decades, and the technology has been used in various industrial and food-processing contexts. What CleanCore did was refine the process, improve the stability and shelf life of the product, format it for ease of use in commercial settings, and market it aggressively as an environmentally and toxicologically superior alternative to traditional disinfectants.

The value proposition is real: traditional disinfectants like sodium hypochlorite (bleach) and quaternary-ammonium compounds are effective but come with genuine drawbacks. They are corrosive, irritating to skin and respiratory systems, environmentally problematic when discharged, and require careful handling and special training. Workers in hospitals, nursing homes, and food-prep environments who handle these chemicals daily face occupational-health exposure. Cleaning with traditional chemicals also generates hazardous waste that must be disposed of specially.

Electrolyzed water, by contrast, decomposes to salt and water after the disinfecting action is complete, meaning no residual toxicity, no special disposal, and lower occupational exposure. If the disinfectant efficacy is genuine and durable, the product could address a real pain point in the facility-management business. The question is whether the economics work for the customer and whether the performance proves consistent in actual use.

The adoption curve and competitive pressure

CleanCore’s adoption depends on facility managers accepting two things: that the product works as well as incumbents for their specific use cases, and that the total cost of ownership — including the product cost, the equipment needed to dispense it, and the labor and waste-management implications — is competitive with existing solutions. Adoption of new cleaning products in hospitals and food-service operations is slow and conservative: regulatory compliance is stringent, and a failed cleaning regimen has patient and food-safety implications.

The company competes against established manufacturers with brands that are household names in their categories and deep relationships with purchasing departments. Bleach, for instance, is ubiquitous, cheap, and understood by everyone. Switching to an unfamiliar product, even if it is technically superior, carries switching costs in training, potential compatibility issues with facility infrastructure, and the perceived risk of adopting something unproven at scale.

CleanCore’s advantage is the wave of environmental and occupational-health regulation pushing in its direction, along with growing customer awareness of chemical exposure. But that trend is long and slow, and the incumbent manufacturers are not standing still — they are launching their own safer formulations and making improvements to traditional products to address the same concerns. CleanCore must win through genuine performance advantage, better economics, or strong brand positioning in specific niches (healthcare or food-service) where the demand for safer products is highest.

Revenue and scaling challenges

CleanCore’s business model is straightforward: it manufactures the electrolyzed-water concentrate, partners with third parties or manages its own equipment (dispensers that produce fresh electrolyzed water on-site) for customer locations, and sells either the concentrate or the equipment-as-a-service. The recurring revenue model is the more valuable version — customers buy or lease the on-site generation equipment and pay subscription fees for the concentrate and the service. This creates predictable, recurring revenue and customer lock-in.

However, scaling that model requires significant capital investment in manufacturing capacity, sales and distribution, and the field support needed to install and maintain equipment at customer sites. For a small company like CleanCore, raising the capital and building the infrastructure to compete with incumbents across major markets is a years-long process. The company is also exposed to customer concentration risk: if a few large healthcare systems or food-service chains represent a large fraction of revenue, the loss of a single account can materially impact results.

The cyclical dimension

CleanCore’s fortunes swing with several macro forces. During economic expansion, facility budgets are robust, capital expenditure on new equipment is easier to justify, and adoption of innovative products accelerates as facility managers have discretionary spending. During downturns, budgets tighten, purchasing becomes conservative, and new-product adoption slows as risk-averse operators stick with known solutions.

Regulatory tightening around chemical exposure and environmental discharge can accelerate adoption in a particular year or region, as facility managers are forced to upgrade protocols or face fines. Regulatory relaxation, conversely, removes the urgency. A disease outbreak (like a health-care-associated infection cluster) can also spike demand for disinfection products, though those cycles are unpredictable and temporary.

The company is also exposed to commodity costs — if the price of salt or the energy cost for electrolysis rises sharply, margins compress. And it is exposed to the maturity of the facilities market: if total spending on cleaning and disinfection is relatively flat year-year, CleanCore can only win market share by taking it from incumbents, which is slower and more competitive than growing in an expanding market.

Researching the claim

For anyone evaluating CleanCore as an investment, the key question is simple: does electrolyzed water actually work as well as traditional disinfectants in real-world facility conditions, and does the economics make sense for the customer? Published studies in hospital settings, food-safety journals, and facility-management literature can shed light on performance. The company’s 10-K filing (SEC CIK 0001956741) should detail customer concentration, installed base, retention rates, and competitive positioning.

The durability case for CleanCore hinges on whether the environmental and occupational-health wave that favors its positioning is strong enough and long enough to justify the company’s valuation and to support growth above and beyond what general facility-spending trends would suggest. That is a judgment call that depends on how seriously one weights regulatory and customer preferences for safer products relative to cost and the demonstrated reluctance of the market to abandon proven, low-cost incumbents quickly.